Aspera Biomedicines
PrivateLast Round
Series A
May 18, 2026
Total Funding Raised
$3.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aspera Biomedicines is a biotechnology company that develops space-accelerated cancer stem cell therapies targeting the ADAR1 protein to prevent cancer relapse.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Space Technology
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspera Biomedicines Comparables
Compare Aspera Biomedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Covant Therapeutics | 78% | |
| STORM Therapeutics | 77% | |
| Accent Therapeutics | 77% | |
Aspera Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 18, 2026 | ||||
| Grant | May 29, 2025 |
Aspera Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
$35M round completed.
Aspera Biomedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aspera Biomedicines's valuation, stock price, and market status.